Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?
- Published In:
- Pharmacology & therapeutics, 196, 44-58 (2019)
- Authors:
- Kleczkowska, Patrycja(2), Nowicka, Katarzyna, Bujalska-Zadrozny, Magdalena, Hermans, Emmanuel
- Database ID:
- RPEP-04282
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04282APA
Kleczkowska, Patrycja; Nowicka, Katarzyna; Bujalska-Zadrozny, Magdalena; Hermans, Emmanuel. (2019). Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?. Pharmacology & therapeutics, 196, 44-58. https://doi.org/10.1016/j.pharmthera.2018.11.007
MLA
Kleczkowska, Patrycja, et al. "Neurokinin-1 receptor-based bivalent drugs in pain management: The journey to nowhere?." Pharmacology & therapeutics, 2019. https://doi.org/10.1016/j.pharmthera.2018.11.007
RethinkPeptides
RethinkPeptides Research Database. "Neurokinin-1 receptor-based bivalent drugs in pain managemen..." RPEP-04282. Retrieved from https://rethinkpeptides.com/research/kleczkowska-2019-neurokinin1-receptorbased-bivalent-drugs
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.